Published in J Infect Dis on March 01, 1984
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol (1988) 3.20
Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol (1990) 2.60
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals. J Clin Microbiol (1991) 2.32
Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. J Clin Microbiol (1990) 2.30
Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev (1988) 2.18
Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Microbiol (1992) 2.17
Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters. Infect Immun (1991) 1.79
Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J Clin Microbiol (1994) 1.68
A novel morbillivirus pneumonia of horses and its transmission to humans. Emerg Infect Dis (1996) 1.62
Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol (1985) 1.57
Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J Clin Microbiol (1989) 1.41
Isolation of Borrelia spirochetes from patients in Texas. J Clin Microbiol (1987) 1.31
The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen. Infect Immun (1992) 1.30
Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol (1989) 1.26
Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program. J Clin Microbiol (1997) 1.25
Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J Clin Microbiol (1989) 1.23
The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi. J Exp Med (1993) 1.22
Comparison of indirect immunofluorescent-antibody assay, enzyme-linked immunosorbent assay, and Western immunoblot for the diagnosis of Lyme disease in dogs. J Clin Microbiol (1990) 1.21
Immunodiagnostic tests for Lyme disease. Yale J Biol Med (1985) 1.18
Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol (1992) 1.11
Evaluation of a quantitative fluorescence immunoassay (FIAX) for detection of serum antibody to Borrelia burgdorferi. J Clin Microbiol (1987) 1.07
Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Microbiol (1994) 1.06
Interlaboratory and intralaboratory comparisons of indirect immunofluorescence assays for serodiagnosis of Lyme disease. J Clin Microbiol (1990) 1.03
Cross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis. J Clin Microbiol (1989) 0.99
Experimental Borrelia garinii infection of Japanese quail. Infect Immun (1994) 0.99
Immunoserology of infectious diseases. Clin Microbiol Rev (1990) 0.99
Comparison of immunofluorescence and enzyme linked immunosorbent assays for diagnosing Lyme disease. J Clin Pathol (1989) 0.98
Dogs as sentinels for Lyme disease in Massachusetts. Am J Public Health (1991) 0.97
Fluoroimmunoassay studies with solubilized antigens from Borrelia burgdorferi. J Clin Microbiol (1989) 0.96
Detection of borreliacidal antibody by using acridine orange and flow cytometry. Clin Diagn Lab Immunol (1994) 0.95
Specific immunofluorescence staining of Treponema pallidum in smears and tissues. J Clin Microbiol (1991) 0.92
Analysis of Leptospira spp., Leptonema illini, and Rickettsia rickettsii for the 39-kilodalton antigen (P39) of Borrelia burgdorferi. J Clin Microbiol (1992) 0.92
Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting. Clin Diagn Lab Immunol (1996) 0.91
Epidemiological and clinical features of 1,149 persons with Lyme disease identified by laboratory-based surveillance in Connecticut. Yale J Biol Med (1989) 0.90
Lyme disease in New Jersey, 1978-1982. Yale J Biol Med (1985) 0.90
Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation. Emerg Infect Dis (1996) 0.89
Adsorption and biotin-streptavidin amplification in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol (1991) 0.88
Characterization of Borrelia coriaceae antigens with monoclonal antibodies. Infect Immun (1991) 0.86
Surface immunofluorescence assay for diagnosis of Lyme disease. J Clin Microbiol (1992) 0.85
110-kilodalton recombinant protein which is immunoreactive with sera from humans, dogs, and horses with Lyme borreliosis. J Clin Microbiol (1991) 0.84
Detection of borreliacidal antibodies in hamsters by using flow cytometry. J Clin Microbiol (1992) 0.82
Caveats on using nonstandardized serologic tests for Lyme disease. J Clin Microbiol (1985) 0.81
Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals? Eur J Epidemiol (1998) 0.80
Prevalence of antibodies to Borrelia burgdorferi in forestry workers of Ile de France, France. Eur J Epidemiol (1997) 0.80
Lyme disease in Australia--still to be proven! Emerg Infect Dis (1996) 0.79
Interlaboratory comparison of titers of antibody to Borrelia burgdorferi and evaluation of a commercial assay using canine sera. J Clin Microbiol (1991) 0.79
Seroepidemiological studies of Borrelia burgdorferi infection in sheep in Norway. J Clin Microbiol (1992) 0.77
Lyme disease: Is it or is it not? Can J Infect Dis Med Microbiol (2005) 0.77
Development and evaluation of a monoclonal antibody inhibition enzyme linked immunosorbent assay to diagnose syphilis. Genitourin Med (1989) 0.76
Lyme disease in Italy: first reported case. Ann Rheum Dis (1985) 0.76
Quality control assessment of Canadian laboratories testing for Lyme disease. Can J Infect Dis (1991) 0.75
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis (1997) 9.69
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85
Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01
Type-specific antigens of group B type Ic streptococci. Infect Immun (1971) 6.84
Identification of 22 Legionella species and 33 serogroups with the slide agglutination test. J Clin Microbiol (1985) 5.81
Indirect immunofluorescence test for serodiagnosis of Legionnaires disease: evidence for serogroup diversity of Legionnaires disease bacterial antigens and for multiple specificity of human antibodies. J Clin Microbiol (1979) 5.03
Recognition of a new serogroup of Legionnaires disease bacterium. J Clin Microbiol (1979) 5.02
Legionella pneumophila serogroup six: isolation from cases of legionellosis, identification by immunofluorescence staining, and immunological response to infection. J Clin Microbiol (1980) 4.90
Atypical Legionella-like organisms: fastidious water-associated bacteria pathogenic for man. Lancet (1979) 4.62
Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization. J Clin Microbiol (1993) 4.13
Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness. J Infect Dis (1984) 3.81
Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect Immun (1973) 3.81
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Identification of group B streptococci by immunofluorescence staining. Appl Microbiol (1974) 3.51
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
Linkage Between the Genes for Sickle Cells and the M-N Blood Types. Science (1947) 2.98
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun (2000) 2.84
Measure of immunoglobulin G-, M-, and A-specific titers against Legionella pneumophila and inhibition of titers against nonspecific, gram-negative bacterial antigens in the indirect immunofluorescence test for legionellosis. J Clin Microbiol (1979) 2.84
Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic. Infect Immun (1975) 2.83
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA (1990) 2.79
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Serological relationships of type I antigens of group B streptococci. J Bacteriol (1969) 2.67
Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol (1987) 2.59
Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera. J Clin Microbiol (1981) 2.56
Legionella jordanis: a new species of Legionella isolated from water and sewage. J Clin Microbiol (1982) 2.39
Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J Infect Dis (1983) 2.28
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Comparison of streptococcal R antigens. Appl Microbiol (1972) 2.19
Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Infect Immun (1994) 2.18
Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med (1982) 2.14
Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol (2001) 2.12
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis (2000) 2.11
The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci. J Immunol (1972) 2.04
The global distribution of Lyme disease. Rev Infect Dis (1985) 1.99
Group B streptococcal infection in humans. Annu Rev Microbiol (1978) 1.95
Nontypable group B streptococci isolated from human sources. J Clin Microbiol (1977) 1.94
Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Microb Pathog (1996) 1.91
CAMP-disk test for presumptive identification of group B streptococci. J Clin Microbiol (1977) 1.90
Second serogroup of Legionella feeleii strains isolated from humans. J Clin Microbiol (1985) 1.88
Evaluation of a commercial gene probe for identification of Legionella cultures. J Clin Microbiol (1986) 1.88
Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol (2000) 1.80
Legionella tucsonensis sp. nov. isolated from a renal transplant recipient. J Clin Microbiol (1989) 1.80
Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis (1990) 1.77
Lyme disease: a selective medium for isolation of the suspected etiological agent, a spirochete. J Clin Microbiol (1984) 1.72
Separation of Treponema pallidum from tissue substances by continuous-flow zonal centrifugation. Appl Microbiol (1972) 1.72
Analysis of group B streptococcal types associated with disease in human infants and adults. J Clin Microbiol (1978) 1.71
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg (2001) 1.66
11th serogroup of Legionella pneumophila isolated from a patient with fatal pneumonia. J Clin Microbiol (1986) 1.61
Evaluation of sera from patients with Lyme disease in the fluorescent treponemal antibody-absorption test for syphilis. Sex Transm Dis (1987) 1.59
Comparison of slide agglutination test and direct immunofluorescence assay for identification of Legionella isolates. J Clin Microbiol (1983) 1.59
Legionellosis. Am J Pathol (1981) 1.59
Pneumonia--a clinical or radiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adults in general practice. Scand J Infect Dis (1992) 1.55
Legionella pneumophila serogroup 14 isolated from patients with fatal pneumonia. J Clin Microbiol (1988) 1.54
Purified 60-kilodalton Legionella protein antigen with Legionella-specific and nonspecific epitopes. J Clin Microbiol (1987) 1.54
Evolving strategies for management of the nongonococcal urethritis syndrome. JAMA (1995) 1.53
The epidemiology of prostate cancer in Jamaica. J Urol (1998) 1.53
Legionella pneumophila serogroup 12 isolated from human and environmental sources. J Clin Microbiol (1987) 1.50
Incessant ovulation and ovarian cancer. Lancet (1991) 1.49
Detection of chlamydiosis in a shipment of pet birds, leading to recognition of an outbreak of clinically mild psittacosis in humans. Clin Infect Dis (1998) 1.49
Second serogroup of Legionella hackeliae isolated from a patient with pneumonia. J Clin Microbiol (1985) 1.48
Practical considerations in using counterimmunoelectrophoresis to identify the principal causative agents of bacterial meningitis. J Clin Microbiol (1979) 1.47
Capillary precipitin typing of Streptococcus pneumoniae. J Clin Microbiol (1978) 1.47
Immunologic response of patients with legionellosis against major protein-containing antigens of Legionella pneumophila serogroup 1 as shown by immunoblot analysis. J Clin Microbiol (1986) 1.46
A one-year study of endemic campylobacteriosis in a midwestern city: association with consumption of raw milk. J Infect Dis (1987) 1.45
Information for pregnant women about caesarean birth. Cochrane Database Syst Rev (2004) 1.45
Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. Am J Epidemiol (1998) 1.43
Slide agglutination test for serogrouping Legionella pneumophila and atypical Legionella-like organisms. J Clin Microbiol (1980) 1.42
Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis (1999) 1.38
Mount St. Helens eruptions: the acute respiratory effects of volcanic ash in a North American community. Arch Environ Health (1983) 1.34
Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale J Biol Med (1985) 1.32
Formalin-killed versus heat-killed Legionella pneumophila serogroup 1 antigen in the indirect immunofluorescence assay for legionellosis. J Clin Microbiol (1982) 1.31
Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid. J Infect Dis (1986) 1.30
Lyme disease in Japan and its possible incriminated tick vector, Ixodes persulcatus. J Infect Dis (1987) 1.28
Legionella cincinnatiensis sp. nov. isolated from a patient with pneumonia. J Clin Microbiol (1988) 1.28
Radioimmunoassay for measuring antibodies specific for group B streptococcal types Ia, Ib, Ic, II, and III. J Clin Microbiol (1976) 1.25
Guanidine extraction of streptococcal M protein. Infect Immun (1975) 1.25
Immunoglobulin specificity of the microagglutination test for the Legionnaires' disease bacterium. Ann Intern Med (1979) 1.23
Toxic shock syndrome: case-control studies at the Centers for Disease Control. Ann Intern Med (1982) 1.23
Legionella pneumophila serogroup 9: a cause of human pneumonia. Ann Intern Med (1984) 1.23
Enzyme-linked immunosorbent assay for streptococcal M protein antibodies. J Clin Microbiol (1976) 1.22
The treatment of chancroid. JAMA (1986) 1.21
Detection of cell-associated or soluble antigens of Legionella pneumophila serogroups 1 to 6, Legionella bozemanii, Legionella dumoffii, Legionella gormanii, and Legionella micdadei by staphylococcal coagglutination tests. J Clin Microbiol (1981) 1.20
Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci. J Clin Microbiol (1978) 1.18
Toxic shock syndrome: the emerging picture. Ann Intern Med (1981) 1.18
Immunodiagnostic tests for Lyme disease. Yale J Biol Med (1985) 1.18
Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae. Clin Diagn Lab Immunol (1998) 1.16
Cross-reactions in Legionella antisera with Bordetella pertussis strains. J Clin Microbiol (1987) 1.15
Enzyme-linked immunosorbent assay for detection of antibodies against Streptococcus pneumoniae capsular polysaccharides. J Clin Microbiol (1980) 1.15
Pathologic findings in twelve fatal cases of toxic shock syndrome. Ann Intern Med (1982) 1.15
Risk factors for development of toxic shock syndrome. Association with a tampon brand. JAMA (1982) 1.13
Peripatetic plague. JAMA (1982) 1.13
A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides. Immunol Invest (2001) 1.13
Vaginal colonization with Staphylococcus aureus in healthy women: a review of four studies. Ann Intern Med (1982) 1.11